ELYXYB
PeakSMcelecoxib
NDAORALSOLUTION
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications (1)
Clinical Trials (5)
Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
Started Jun 2022
59 enrolled
Healthy Volunteers
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Started Jan 2019
53 enrolled
Malignant Pleural Mesothelioma
Celecoxib After Tonsillectomy
Started Jun 2016
172 enrolled
Tonsillectomy
Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis
Started May 2016
380 enrolled
OsteoarthritisOsteoarthritis, Knee
Effect of AKB-6548 on the Pharmacokinetics of Celecoxib
Started Jul 2015
12 enrolled
Healthy Volunteers
Loss of Exclusivity
LOE Date
May 27, 2036
124 months away
Patent Expiry
May 27, 2036